How Sculptide® Works

Understanding the mechanism of action of tirzepatide at a high level.

Mechanism of Action

Sculptide® contains tirzepatide, which is designed to act as a dual GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptor agonist.

These naturally occurring hormones are involved in various metabolic processes. Tirzepatide has been shown in clinical studies to act on the receptors associated with these hormones.

Clinical Evidence

The mechanism described is based on clinical research. Individual responses may vary, and this information does not guarantee specific outcomes.

Understanding the Approach

GLP-1 Receptor Activity
Tirzepatide is designed to act on GLP-1 receptors, which have been shown in clinical studies to be associated with appetite regulation mechanisms in the body.
GIP Receptor Activity
In addition to GLP-1 activity, tirzepatide is designed to act on GIP receptors, which have been shown in clinical studies to be involved in metabolic processes.

Appetite Regulation

Clinical studies have shown that tirzepatide acts on pathways associated with appetite regulation. The dual receptor agonist approach is designed to influence these natural metabolic processes.

The medication is intended to be used as part of a comprehensive weight management programme, which may include dietary modifications and increased physical activity as recommended by a healthcare professional.

No Outcome Guarantees

Individual responses to treatment vary. This information describes the mechanism of action and does not promise specific outcomes or timelines.

Important Clinical Context

The information provided on this page describes the general mechanism of action of tirzepatide based on published clinical research. This information is provided for educational purposes only and does not constitute medical advice. Treatment decisions should always be made in consultation with a qualified healthcare professional who can assess individual circumstances, medical history, and suitability for treatment.